Black Rock Inc. Royalty Pharma PLC Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Black Rock Inc. holds 21,205,841 shares of RPRX stock, worth $559 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,205,841
Previous 21,459,462
1.18%
Holding current value
$559 Million
Previous $603 Million
6.84%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding RPRX
# of Institutions
394Shares Held
275MCall Options Held
276KPut Options Held
236K-
Morgan Stanley New York, NY44.2MShares$1.17 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.7MShares$994 Million0.02% of portfolio
-
Baillie Gifford & CO16.7MShares$439 Million0.4% of portfolio
-
Viking Global Investors LP11.5MShares$303 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.8MShares$285 Million0.64% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...